Scopolamine Patch, Extended Release
Product Images NDC 50742-505

Not available.*

The text describes an image labeled "Figure 1", which shows a disposable plastic release liner with a metallic adhesive surface and stipples. The backing membrane is tan, and there is an imprint that reads "Scopolamine 1 mg/3 days". It is unclear what the purpose or context of this image is.*

The given text is a simple instruction to tear open a pouch following the dashed lines indicated on it. It is accompanied by a reference to "Figure 2", which might provide a visual aid or context for the pouch.*

The text describes a tan-colored, transdermal system with a metallic adhesive surface. It includes a clear, disposable plastic release liner with stipples. Figure 4 is referenced, but no further information is provided.*

The text is describing a transdermal system that is tan-colored and imprinted with a "G". A figure (presumably a visual representation) labeled as "Figure 5" is also mentioned.*

This is a medication packaging for Scopolamine Transdermal System, which contains a single transdermal patch that delivers 1mg of scopolamine over the course of 3 days. The label warns to wash hands after handling and indicates that it is a prescription medication.*

Scopolamine Transdermal System is a medication used for the prevention of motion sickness, post-operative nausea, and vomiting. The system contains four transdermal systems, each delivering approximately 1 mg over three days through a standardized pressure-sensitive acrylic adhesive layer. The systems contain a polyester backing film, a siliconized PET release liner, and a highly permeable, clear, polyacrylate adhesive membrane attached to a nonwoven polyester fabric. The medication guide should be dispensed to each patient. The pharmacist should caution patients that the product may cause drowsiness and should be removed before undergoing an MRI procedure. The medication and the patch should be kept out of reach of children, stored below 77°F (25°C), and protected from light. If there are any questions or concerns, patients can contact the manufacturer.*

Scopolamine Transdermal System is a medication used to prevent motion sickness and post-operative nausea and vomiting. It is a transdermal system containing 1mg scopolamine formulated to deliver the medication over three days. Each package contains 10 transdermal systems. The pharmacist should dispense the accompanying Medication Guide to each patient. The active components include aminized polyester acin, silconized PET glass, and scopolamine. The system should be applied to a clean, dry area and not be exposed to water while it is wearing. It may cause drowsiness, so be cautious about performing tasks requiring alertness. Keep the system away from children and store at a controlled room temperature between 68°F and 77°F. For more information, contact the manufacturer.*

Description: Scopolamine Transdermal System is a medication used to prevent motion sickness and post-operative nausea and vomiting. It comes in the form of 1mg/3 days transdermal systems, containing 24 such systems. The medication guide is available for this product. However, no other text is readable.*

This is a description of a scopolamine transdermal system, which is a patch that delivers 1.5 mg of scopolamine over 3 days. It consists of various materials, including an acrylic adhesive, polyethylene backing, and ink containing pigments. The patch should be applied to a hairless area behind one ear and should not be used if the seal is broken. Caution should be taken to avoid burns or MRI interference. It is manufactured by Ingenus Pharmaceuticals in Orlando, Florida.*

This is a typical layered structure of a transdermal patch. It contains a backing membrane, followed by two layers of a drug in adhesive, with a rate controlling membrane in between. The patch is covered with a release liner which is removed before application.*